BackGenfit Overview

Genfit EBIT

Latest ebit for GNFT: $6.2M, below the Healthcare sector average of $22B.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$63.00K
99.6% YoY

As of Jun 30, 2025

Annual EBIT (TTM)

$6.15M
113.94% YoY

Trailing 12 months ending Jun 30, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Genfit (GNFT) FAQ

Genfit (GNFT) currently reports a EBIT of $6.2M as of June 2025. That compares with $-44M in the prior-year period — up 113.9% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Genfit's EBIT history and peer comparisons.

Genfit's EBIT increased from $-44M to $6.2M — a 113.9% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Genfit's EBIT of $6.2M is lower than the Healthcare sector average of $22B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Genfit reported $6.2M in EBIT as of June 2025. That compares with $-44M in the prior-year period — up 113.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $6.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Genfit, and consider following GNFT for alerts when major investors trade the stock.